CytomX Therapeutics - 48 Year Dividend Yield History | CTMX

Historical dividend payout and yield for CytomX Therapeutics (CTMX) since 1971. The current TTM dividend payout for CytomX Therapeutics (CTMX) as of February 15, 2019 is $0.00. The current dividend yield for CytomX Therapeutics as of February 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.829B $0.072B
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Bio-Techne Corp (TECH) United States $7.237B 48.76